Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
anastrozole (arimidex) (1 trial)
capecitabine (xeloda) (1 trial)
gimeracil (1 trial)
oteracil (1 trial)
s-1 (1 trial)
tegafur (1 trial)
toremifene (fareston) (1 trial)
Breast Neoplasms (Phase 2)
Trials (2 total)
Trial APIs (7 total)